Archive
2775 published stories · page 40 of 185. Editor summaries with links to original reporting — see Editorial analysis for original commentary, or Latest on the hub.
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
Angus Taylor and Matt Canavan claim drastic cut to price of cigarettes and moves to legalise vapes will combat illicit tobacco tradeFollow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcastLeading public health experts, t...
New international consensus addresses a long-standing gap in diabetes care with practical, evidence-informed guidance for clinicians An international panel of 35 experts from 13 countries has published the world’s first […]
CDC launches a central data channel to track overdose trends and strengthen prevention nationwide.
Cochrane最新回顧顯示，受管制的含尼古丁電子煙在部分研究中提高戒菸率；但研究結果、長期安全與台灣現行禁令必須分開判讀。Read more at 蒸氣研習社
英國10月29日起把18歲銷售門檻擴及更多電子煙與尼古丁產品，代購、促銷贈品及大幅折扣也將受限制；此制度不可套用為台灣合法依據。Read more at 蒸氣研習社
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
A popular vanilla flavoring in e-cigarettes may interfere with some of the earliest steps of human development. In lab experiments, vanillin caused embryonic stem cells to lose their ability to develop normally and pushed them toward forming only certain types of tissue.
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound.
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound.
